I know how I am going to react. Orbimed would have had a very...

I know how I am going to react. Orbimed would have had a very good look under the bonnet and into the pipeline to hand over $40 mil. I get the feeling this funding could be the catalyst for more deals which have been lined up and waiting.

With recent Hikima results and our imminent production ramp up AND 20 million shares on the Nasdaq short, we could be looking a real rerate over the next week or so.

Commiserations to the shorts.